Share Prices & Company Research

Stockbroking

Allergy Therapeutics

Current Price 13.97p Bid 13.50p Ask 14.50p Change 0.00%
Last Updated: 11/12/2018 13:06. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Allergy Therapeutics plc is an international specialty pharmaceutical group focussed on the treatment and diagnosis of allergic disorders, including immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries. Its broad pipeline of products in clinical development include vaccines for grass, tree and house dust mite, and peanut allergy vaccine in pre-clinical development. Adjuvant systems to boost performance of vaccines outside allergy are also in development. Formed in 1999 out of Smith Kline Beecham, Allergy Therapeutics is headquartered in Worthing, UK.

Financial Highlights Year Ended 30/06/2018

Turnover
£68.35m
Operating Profit
£-6.73m
Dividend Yield
0.00
Dividend Per Share
0.00
Dividend Cover
0.00
P/E Ratio
-11.02

Key Personnel

Manuel Llobet
Chief Executive Officer
Nicolas Alexander Ulrich Wykeman
Finance Director
Peter Sinclair Jensen
Non-Executive Chairman
Dr Babatunde Adekunle Otulana
Non-Executive Director
Stephen Rushworth Smith
Non-Executive Director
Scott Michael Leinenweber
Non-Executive Director

Stock Details

EPIC
AGY
ISIN
GB00B02LCQ05
Shares in Issue
636,168,616
Market cap
£89.06m

Analyst Views (2)

Strong Buy
 
50.00%
Buy
 
0.00%
Hold
 
50.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
14.00p
Bid Price
13.50p
Ask Price
14.50p
Volume
0
Change Today
0.00p
% Change Today
0.00%
Open
0.00p
Previous Close
14.00p
Intraday High
0.00p
Intraday Low
0.00p
52 Week High
31.75p
52 Week Low
13.75p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Allergy Therapeutics Intra-day Chart

Assets (£m)

Data has been provided by MoneyAM

Reporting Date
30 Jun 2018
30 Jun 2017
Tangible Assets
10.1
9.7
Intangible Assets & Goodwill
5.0
5.5
Investments & Other Non-Current Assets
5.0
4.6
Total Non-Current Assets
20.1
19.7
Inventory
8.8
7.5
Trade & Receivables
6.6
7.9
Cash & Receivables
15.5
22.1
Other Current Assets & Assets Held for Resale
0.0
0.0
Total Assets
51.0
57.2

Liabilities (£m)

Data has been provided by MoneyAM

Reporting Date
30 Jun 2018
30 Jun 2017
Short Term Liabilities
14.6
14.0
Long Term Liabilities
13.4
13.2
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
28.0
27.2

Net Assets (£m)

Data has been provided by MoneyAM

Reporting Date
30 Jun 2018
30 Jun 2017
Net Assets
23.0
30.0

Equity (£m)

Data has been provided by MoneyAM

Reporting Date
30 Jun 2018
30 Jun 2017
Share Capital
0.6
0.6
Minority Interests
0.0
0.0
Retained Earnings
-121.8
-114.4
Share Premium Account
102.4
102.4
Other Equity
41.8
41.4
Total Equity
23.0
30.0

Cashflow (£m)

Data has been provided by MoneyAM

Reporting Date
30 Jun 2018
30 Jun 2017
Cashflow from Operating Activities
-3.8
0.2
Cashflow Before Financing
-6.3
-1.8
Increase / Decrease in Cash
-6.6
-2.0

Income (£m)

Data has been provided by MoneyAM

Reporting Date
30 Jun 2018
30 Jun 2017
Turnover
68.4
64.1
Cost of Sales
17.0
16.8
Gross Profit
51.3
47.4
Operating Profit
-6.7
-1.9
Pre-Tax Profit
-6.9
-2.0
Profit / Loss for the Year
-7.5
-2.5
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.